Original Research
Published on 22 Nov 2024
Distinct clinico-genomic factors drive outcomes in patients with myelofibrosis and disease-related anemia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1492680
Type at least 3 characters
107 articles
Articles
Case Report
Accepted on 19 Nov 2024
Ruxolitinib and Peg-Interferon in Chronic neutrophilic leukemia due to CSF3R germline pathogenic variant: a case report
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1508463
Correction
Accepted on 18 Nov 2024
Refractory human cytomegalovirus infection without evidence of genetic resistance in the UL-54 and UL-97 genes in a pediatric hematopoietic stem cell transplant recipient: a case report
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1526535
Review
Accepted on 18 Nov 2024
Delineation of Erythropoietic Intermediates by Flow Cytometry Author
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2024.1496916
Case Report
Accepted on 18 Nov 2024
Vitamin B12 Deficiency-Associated Hemolytic Anemia: Case Series
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2024.1446241
Original Research
Accepted on 15 Nov 2024
Prevalence of Measurable Residual Disease (MRD) in Patients with refractory/relapsed Multiple Myeloma who Reached Complete Response: A Cross-sectional Multicentric Study
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1480120
Case Report
Published on 15 Nov 2024
Late onset pancytopenia post chimeric antigen receptor T cell therapy triggered by a COVID-19 vaccination: a case report
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2024.1435584
- 198 views
Case Report
Published on 13 Nov 2024
Case report: VEXAS syndrome and literature review
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1480436
- 140 views
Original Research
Accepted on 07 Nov 2024
Unique target binding by the C-terminal Region of FHR1 provides a new perception of aHUS Pathology
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2024.1469176
Mini Review
Accepted on 05 Nov 2024
Not just for mature audiences: myeloproliferative neoplasms in children, adolescents, and young adults
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1483322
Original Research
Accepted on 04 Nov 2024
Exploring the regenerative capacity of the spleen following irradiation
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2024.1396672
Case Report
Accepted on 31 Oct 2024
A Rare Case of CNS-CLL Mimicking Demyelinating Disease: Multidisciplinary Approaches for Accurate Diagnosis
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1496758
Review
Published on 29 Oct 2024
Early T-cell precursor acute lymphoblastic leukemia: diagnostic pitfalls, genomic alteration, novel therapeutics, and minimal residual disease monitoring
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1463410
- 335 views
Original Research
Accepted on 28 Oct 2024
Rare cell-based liquid biopsy for improved measurement of low-grade chronic inflammation
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2024.1472609
Editorial
Published on 18 Oct 2024
Editorial: Editors’ showcase: red cells, iron and erythropoiesis
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2024.1457513
- 150 views
Perspective
Published on 18 Oct 2024
The CHIP-clinic as the catalyst of preventive medicine
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1459154
- 368 views